Department of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center, Dallas, Texas , USA.
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington , USA.
Brain Inj. 2021 Jan 18;35(2):180-188. doi: 10.1080/02699052.2021.1871952. Epub 2021 Jan 17.
: To examine the impact of bright white light (BWL) exposure on sleep quality in persons with recent traumatic brain injury (TBI).: Randomized, controlled device-sham study: 3 TBI Model System inpatient rehabilitation units: 131 participants (mean 40.9 years, 68% male): Intervention group (N = 65) received BWL (1260 lux at 20 inches, 440-480 nanometers length) for 30 minutes each morning at 12-24 inches from the face. Control group (N = 66) received red light (<450 lux, no light between 440 and 480 nanometers) for the same period. Planned intervention was maximum of 10 treatments or until discharge.: Sleep duration and quality using actigraphic recording.: There were no differences found between groups on the primary outcomes nor on the secondary outcomes (sleepiness, mood, cooperation with therapy).: BWL treatment during acute rehabilitation hospitalization does not appear to impact sleep or measures commonly associated with sleep. While studies have indicated common complaints of sleep difficulties after TBI, we were unable to document an effect for phototherapy as a treatment. With growing evidence of the effect of sleep on neural repair and cognition, further study is needed to understand the nature and treatment of sleep disorders after TBI.Clinicaltrials.gov Identifier: NCT02214212.
: 探讨明亮白光(BWL)暴露对近期创伤性脑损伤(TBI)患者睡眠质量的影响。: 随机、对照设备模拟研究:3 个 TBI 模型系统住院康复病房:131 名参与者(平均年龄 40.9 岁,68%为男性):干预组(N=65)每天早上在距离面部 12-24 英寸处接受 BWL(1260 勒克斯,波长 440-480 纳米)照射 30 分钟。对照组(N=66)接受相同时间的红光(<450 勒克斯,波长 440-480 纳米之间无光照)。计划干预最多 10 次治疗或直到出院。:使用活动记录仪记录睡眠持续时间和质量。:两组在主要结局和次要结局(嗜睡、情绪、对治疗的合作)上均无差异。:急性康复住院期间的 BWL 治疗似乎不会影响睡眠或与睡眠相关的常见指标。尽管研究表明 TBI 后常见的睡眠困难投诉,但我们无法证明光疗作为一种治疗方法有效。鉴于睡眠对神经修复和认知的影响越来越多的证据,需要进一步研究以了解 TBI 后睡眠障碍的性质和治疗方法。临床试验注册编号:NCT02214212。